Biosurgical Agents | Medtech 360 | Market Insights | Asia Pacific

Publish date: December 2017

Login to access report

The Asia Pacific market for biosurgical agents will grow moderately due to rising surgery volumes, which will drive unit sales; however, growing concerns over product cost and competition from local competitors will limit ASPs in this market to some extent.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for biosurgical agents in the Asia Pacific region across a 10-year period.


Increasing surgical procedure volumes in the Asia Pacific region will largely dictate growth of the overall market.

Which surgical specialties contribute most to biosurgical agent revenues?

What impact will the expanding use of minimally invasive surgical techniques have on the biosurgical agent market?

There are several biosurgical agent products that are not currently approved in some Asia Pacific countries, and the use of some products is affected by cultural differences in the region.

Which products are currently unavailable in the Asia Pacific countries? Are these products expected to gain approval in these countries within the forecast period?

For which biosurgical agents will cultural differences negatively impact unit sales?

The Asia Pacific biosurgical agent market remains underpenetrated compared to the US and Europe, but companies are targeting this region due to its growth potential.

What strategies are competitors using to target the Asia Pacific biosurgical agent market? 

What types of challenges will companies face in this space, and what will they need to do to overcome these difficulties?

Table of contents

  • Asia Pacific
    • Executive Summary
      • Market Highlights
      • Competitive Highlights
      • Market Developments
      • Key Report Updates
      • Geographies Covered
      • Products Covered
    • Version History
    • Biosurgical Agent Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Clinical Data
        • Physician Training and Marketing
        • Product Improvements and Innovation
        • Reimbursement
        • Regulatory Environment
        • Pricing Strategies
        • Product Portfolio Management
        • Distribution and Sales Network
      • Market Developments
    • Surgical Hemostat Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Product Improvements and Innovations
    • Internal Tissue Sealant Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Clinical Data
        • Product Improvements and Innovations
    • Adhesion Barrier Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Clinical Data
        • Product Improvements and Innovations
    • Appendix
      • Abbreviations
      • Bibliography
    • Abstract

Author(s): P Prasad, MS

Prasad Pallemsetty is a senior analyst within the Endoscopy and Aesthetics Medtech Insights team at Decision Resources Group, specializing in the fields of gastroenterology and bariatrics. Prasad holds a Bachelor’s degree in Pharmacy from SRM University and a Master’s degree in Pharmaceutics from Rajiv Gandhi University, India.